View Document Preview and Link Document Date: 2009-12-08 04:25:30 Open Document File Size: 156,98 KB Share Result on Facebook
City Hyderabad / / Company Aurobindo Pharma Ltd. / mL Aurobindo Pharma Ltd. / / Country India / / Event FDA Phase / / Facility STORING ZIDOVUDINE ORAL SOLUTION Store / / IndustryTerm drug product / manufacturing practices / food / HIV treatment / active pharmaceutical ingredient / treatment of HIV / manufacturing / healthcare professional / / MedicalCondition HIV / serious liver disease / headache / myopathy / stomach pain / leukopenia / liver failure / coma / nausea / thrombocytopenia / advanced HIV disease / sleeplessness / severe anemia / fatigue / drowsiness / muscle disorders / early HIV disease / diarrhea / hyperlipemia / hepatitis / aplastic anemia / fatal hepatitis / liver disease / infections / cramps / severe lactic acidosis / HIV infection / abdominal pain / insomnia / opportunistic infections / disease / kidney disease / advanced HIV infection / aches / neutropenia / itching / vomiting / lactic acidosis / opportunistic infection / Virus (HIV) infection / hepatic failure / AIDS / HIV/AIDS / infection / renal failure / inflammation / depression / rash / chronic hepatitis B / anemia / HIV disease / dehydration / / MedicalTreatment antiretroviral therapy / / Organization World Health Organization / United Nations / U. S. Food and Drug Administration / / / Position President / pharmacist / / Product probenecid / Zidovudine / fluconazole / dapsone / ganciclovir / ribavirin / valproic acid / stavudine / Zidovudine Oral Solution / Zidovudine Syrup / / ProvinceOrState Andhra Pradesh / / Technology API / / SocialTag 
USFDA Approval September 19, 2005 Zidovudine Syrup (Zidovudine Oral Solution) 50 mg/5 mL Aurobindo Pharma, Ltd. 1